Nantahala Capital Management, LLC 13D and 13G filings for Unicycive Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-20 4:32 pm Purchase |
2024-12-19 | 13G | Unicycive Therapeutics, Inc. UNCY |
Nantahala Capital Management, LLC | 10,879,142 9.990% |
719,793 (+7.09%) |
Filing |
| 2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY |
Nantahala Capital Management, LLC | 10,159,349 9.990% |
6,683,636 (+192.30%) |
Filing |
| 2024-02-14 4:51 pm Purchase |
2023-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
Nantahala Capital Management, LLC | 3,475,713 9.900% |
2,268,297 (+187.86%) |
Filing |
| 2023-02-14 4:52 pm Sale |
2022-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
Nantahala Capital Management, LLC | 1,207,416 8.000% |
-39,340 (-3.16%) |
Filing |
| 2022-02-14 08:35 am Purchase |
2021-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
Nantahala Capital Management, LLC | 1,246,756 8.000% |
1,246,756 (New Position) |
Filing |